Results 1 to 10 of about 3,843,014 (290)
Percutaneous technique of concomitant right ventricular assist device placement during left ventricular assist device implantationCentral Message [PDF]
Michelle Carvajal, MD +3 more
doaj +2 more sources
Left Ventricular Assist Device-Related Complications
Left ventricular assist device (LVAD) has emerged as a safe, durable, and revolutionary therapy for end-stage heart failure patients. Despite the appearance of newer-generation devices that have improved patient outcomes, the burden of adverse events ...
Clement Alexandra +3 more
doaj +1 more source
Background Cardiogenic shock (CS) is a complex syndrome associated with high morbidity and mortality. In recent years, many US hospitals have formed multidisciplinary shock teams capable of rapid diagnosis and triage. Because of preexisting collaborative
Joseph I. Wang +10 more
doaj +1 more source
Left Ventricular Assist Device (LVAD) Implantation and Renal Dysfunction [PDF]
Pathophysiological, pathomorphological and functional changes in the kidneys after left ventricular assist device implantation have not yet been fully understood and represent an actual problem of our time.
Assem Nogaibayeva +2 more
doaj +1 more source
Understanding Left Ventricular Assist Devices
<b><i>Background/Aims:</i></b> Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity.
Aissaoui, Nadia (Dr. rer. nat.) +8 more
openaire +3 more sources
Hydraulic performance of Continuous Flow Left Ventricular Assist Devices depends on their pressure head and flow rate relations. Hydraulic characteristics of these devices are expressed by pressure head and flow rate loops in a pulsatile environment as ...
Selim Bozkurt
doaj +1 more source
Left Ventricular Assist Devices Are Underutilized [PDF]
Heart failure has become one of the fastest growing cardiovascular diagnoses, with estimates as high as 500 000 new cases per year.1,2 This growth is in part a result of the reductions in death from acute coronary syndromes, increased use of implantable cardioverter defibrillators, and improved survival with most cardiovascular interventions, which ...
openaire +2 more sources
Targeted myocardial gene expression in failing hearts by RNA sequencing
Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly variable and difficult to predict. Next generation ribonucleic acid (RNA) sequencing is an innovative, rapid, and quantitative approach to gene expression ...
Kajari Dhar +12 more
doaj +1 more source
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov +4 more
doaj +1 more source
Left Ventricular Assist Device Outflow Cannula Obstruction
One of the dreaded complications of left ventricular assist device implantation is mechanical obstruction of the device secondary to pump thrombosis or mechanical outflow cannula obstruction.
Majid Asawaeer, MD +4 more
doaj +1 more source

